Vertex Pharmaceuticals Incorporated
CRYSTALLINE FORMS OF C21H22Cl2N4O2
Last updated:
Abstract:
The present invention provides crystalline forms of a compound of formula (I): ##STR00001## Also provided are pharmaceutical compositions that include the provided crystalline forms and methods of using the provided crystalline forms and pharmaceutical compositions for the treatment of cancer.
Status:
Application
Type:
Utility
Filling date:
7 Jul 2020
Issue date:
29 Oct 2020